...
首页> 外文期刊>Advanced Biomedical Research >Intracranial meningiomas: Prognostic factors and treatment outcome in patients undergoing postoperative radiation therapy
【24h】

Intracranial meningiomas: Prognostic factors and treatment outcome in patients undergoing postoperative radiation therapy

机译:颅内脑膜瘤:术后放射治疗患者的预后因素和治疗结果

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Meningioma constitutes 20% of the intracranial neoplasms. Followed by surgery as the primary treatment for most patients, radiotherapy becomes indicated in high-grade tumors with incomplete surgical removal. We evaluated the prognostic factors and overall outcome in meningioma patients who underwent radiotherapy. Materials and Methods: In this retrospective analysis, data from all patients with documented diagnosis of meningioma who referred to the Omid and Ghaem Oncology Centers (Mashhad, Iran) from 2002 to 2013 were included. We calculated the overall survival rates using the Kaplan–Meier method and compared the survival curves between groups by the log-rank test. Results: Eighty-three patients with a median age of 50 years (ranging: 16–84) were included. Grade I, II, and III meningiomas were seen in 40 (48%), 31 (37%), and 12 (15%) patients, respectively. Radiation therapy was indicated due to tumor recurrence, incomplete excision, or tumor grade in 32, 8, and 43 patients, respectively. Tumor grade had a significant effect on the overall survival with a 3-year overall survival of 76.7%, 43.5%, and 13.3% in Grade I, II, and III, respectively ( P < 0.001). Gender, age, and tumor location were not correlated with the overall survival. Moreover, patients with Grade II and III who underwent total resection had a significantly higher overall survival than those with subtotal resection or biopsy alone (5-year survival rates of 82% vs. 17.1%, respectively; P = 0.008). Conclusion: Tumor grade was the most important prognostic factor in meningioma patients undergoing radiation therapy. In patients with Grade II and III tumors, the extent of surgical resection is significantly correlated with the overall survival.
机译:背景:脑膜瘤占颅内肿瘤的20%。外科手术是大多数患者的主要治疗方法,放疗已成为高度肿瘤且手术切除不完全的适应症。我们评估了接受放射治疗的脑膜瘤患者的预后因素和总体预后。资料和方法:在这项回顾性分析中,纳入了2002年至2013年间转诊至Omid and Ghaem肿瘤学中心(伊朗马什哈德)的所有确诊为脑膜瘤的患者的数据。我们使用Kaplan-Meier方法计算了总生存率,并通过对数秩检验比较了各组之间的生存曲线。结果:八十三名患者的中位年龄为50岁(范围:16-84岁)。分别在40(48%),31(37%)和12(15%)的患者中发现了I,II和III级脑膜瘤。分别由于32例,8例和43例患者的肿瘤复发,切除不完全或肿瘤分级提示放疗。肿瘤等级对总生存期有显着影响,I,II和III级的3年总生存率分别为76.7%,43.5%和13.3%(P <0.001)。性别,年龄和肿瘤位置与总生存率无关。此外,接受全切除术的II级和III级患者的总生存率显着高于仅进行次全切除术或活检的患者(5年生存率分别为82%和17.1%; P = 0.008)。结论:肿瘤分级是脑膜瘤放疗患者最重要的预后因素。在患有II级和III级肿瘤的患者中,手术切除的程度与总体生存率显着相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号